Barrett & Company, Inc. Viatris Inc Transaction History
Barrett & Company, Inc.
- $231 Billion
- Q3 2024
A detailed history of Barrett & Company, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Barrett & Company, Inc. holds 1,172 shares of VTRS stock, worth $13,958. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,172
Previous 1,179
0.59%
Holding current value
$13,958
Previous $12.5 Million
8.59%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding VTRS
# of Institutions
1,083Shares Held
970MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.67 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.1 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$740 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$685 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$677 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $14.4B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...